Skip to main content
SpringerLink
Log in

Acute Ischemic Stroke

  • Chapter
Book cover Handbook of Cerebrovascular Disease and Neurointerventional Technique

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 1553 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. AHA Heart Disease and Stroke Statistics-2004 Update. Dallas, TX: American Heart Association; 2003, pp. 1–52

    Google Scholar 

  2. Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing between stroke and mimic at the bedside: The brain attack study. Stroke 2006;37(3):769–75

    PubMed  Google Scholar 

  3. Foster JW, Hart RG. Hypoglycemic hemiplegia: Two cases and a clinical review. Stroke 1987;18(5):944–6

    PubMed  CAS  Google Scholar 

  4. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: A prospective multicenter study. Arch Neurol 2000;57(11):1617–22

    PubMed  CAS  Google Scholar 

  5. Sylaja PN, Dzialowski I, Krol A, Roy J, Federico P, Demchuk AM. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset. Stroke 2006;37(3):915–7

    PubMed  CAS  Google Scholar 

  6. Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I. Seizure at stroke onset: Should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis 2002;14(1):54–7

    PubMed  Google Scholar 

  7. Benditt DG, van Dijk JG, Sutton R, et al. Syncope. Curr Probl Cardiol 2004;29(4):152–229

    PubMed  Google Scholar 

  8. Arboix A, Massons J, Oliveres M, Arribas MP, Titus F. Headache in acute cerebrovascular disease: A prospective clinical study in 240 patients. Cephalalgia 1994;14(1):37–40

    PubMed  CAS  Google Scholar 

  9. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(2):577–617

    PubMed  Google Scholar 

  10. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(6):1583–633

    PubMed  Google Scholar 

  11. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: The excess burden of stroke among blacks. Stroke 2004;35(2):426–31

    PubMed  Google Scholar 

  12. Amarenco P. Cryptogenic stroke, aortic arch atheroma, patent foramen ovale, and the risk of stroke. Cerebrovasc Dis 2005;20(Suppl 2):68–74

    PubMed  Google Scholar 

  13. Molisse TA, Tunick PA, Kronzon I. Complications of aortic atherosclerosis: Atheroemboli and thromboemboli. Curr Treat Options Cardiovasc Med 2007;9(2):137–47

    PubMed  Google Scholar 

  14. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: Efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998;31(1):134–8

    PubMed  CAS  Google Scholar 

  15. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants. J Am Coll Cardiol 1999;33(5):1317–22

    PubMed  CAS  Google Scholar 

  16. Lutsep HL. MATCH results: Implications for the internist. Am J Med 2006;119(6):526 e1–7

    PubMed  Google Scholar 

  17. Orencia AJ, Hammill SC, Whisnant J P. Sinus node dysfunction and ischemic stroke. Heart Dis Stroke 1994; 3(2):91–4

    PubMed  CAS  Google Scholar 

  18. Scholten MF, Thornton AS, Mekel JM, Koudstaal PJ, Jordaens LJ. Anticoagulation in atrial fibrillation and flutter. Europace 2005;7(5):492–9

    PubMed  CAS  Google Scholar 

  19. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35(1):183–7

    CAS  Google Scholar 

  20. Medi C, Hankey GJ, Freedman SB. Atrial fibrillation. Med J Aust 2007;186(4):197–202

    PubMed  Google Scholar 

  21. Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med 2007;120(6):481–7

    PubMed  Google Scholar 

  22. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001;285(22):2864–70

    CAS  Google Scholar 

  23. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;131(7):492–501

    PubMed  CAS  Google Scholar 

  24. Petty GW, Brown RD, Jr., Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med 1999;130(1):14–22

    PubMed  CAS  Google Scholar 

  25. Rensink AA, de Waal RM, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 2003;43(2):207–23

    PubMed  CAS  Google Scholar 

  26. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68(17):1411–6

    PubMed  CAS  Google Scholar 

  27. Razvi SS, Bone I. Single gene disorders causing ischaemic stroke. J Neurol 2006;253(6):685–700

    PubMed  Google Scholar 

  28. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336(4):251–7

    PubMed  CAS  Google Scholar 

  29. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327(10):669–77

    CAS  Google Scholar 

  30. Thomas D P, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997;126(8):638–44

    PubMed  CAS  Google Scholar 

  31. Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000;31(12):3067–78

    PubMed  CAS  Google Scholar 

  32. Hart RG, Kanter MC. Hematologic disorders and ischemic stroke. A selective review. Stroke 1990;21(8):1111–21

    CAS  Google Scholar 

  33. Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2005:462–8

    Google Scholar 

  34. Elkind MS. Inflammation, atherosclerosis, and stroke. Neurologist 2006;12(3):140–8

    PubMed  Google Scholar 

  35. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The Bruneck study. Diabetes Care 2007;30(2):318–24

    PubMed  Google Scholar 

  36. Bashore TM, Cabell C, Fowler V, Jr. Update on infective endocarditis. Curr Probl Cardiol 2006;31(4):274–352

    PubMed  Google Scholar 

  37. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: Pathogenesis, diagnosis, and treatment. Oncologist 2007;12(5):518–23

    PubMed  Google Scholar 

  38. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: A review. Am Heart J 1987;113(3):773–84

    PubMed  CAS  Google Scholar 

  39. Rabinstein AA, Giovanelli C, Romano JG, Koch S, Forteza AM, Ricci M. Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke. J Neurol 2005;252(3):352–5

    PubMed  CAS  Google Scholar 

  40. White H, Boden-Albala B, Wang C, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: The Northern Manhattan Study. Circulation 2005;111(10):1327–31

    PubMed  Google Scholar 

  41. Clarke JT. Narrative review: Fabry disease. Ann Intern Med 2007;146(6):425–33

    PubMed  Google Scholar 

  42. Markus HS, Alberts MJ. Update on genetics of stroke and cerebrovascular disease 2005. Stroke 2006;37(2):288–90

    PubMed  Google Scholar 

  43. Daneschvar HL, Daw H. Heparin-induced thrombocytopenia (an overview). Int J Clin Pract 2007;61(1):130–7

    PubMed  CAS  Google Scholar 

  44. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006;355(8):809–17

    CAS  Google Scholar 

  45. Suzuki S, Brown CM, Wise PM. Mechanisms of neuroprotection by estrogen. Endocrine 2006;29(2):209–15

    PubMed  CAS  Google Scholar 

  46. Yang SH, Liu R, Perez EJ, Wang X, Simpkins JW. Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord 2005;4(2):169–77

    PubMed  CAS  Google Scholar 

  47. Merchenthaler I, Dellovade TL, Shughrue PJ. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann NY Acad Sci 2003;1007:89–100

    PubMed  CAS  Google Scholar 

  48. Hurn PD, Macrae IM. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000;20(4):631–52

    PubMed  CAS  Google Scholar 

  49. Bushnell CD. Oestrogen and stroke in women: Assessment of risk. Lancet Neurol 2005;4(11):743–51

    PubMed  CAS  Google Scholar 

  50. Simon JA, Hsia J, Cauley JA, et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 2001;103(5):638–42

    PubMed  CAS  Google Scholar 

  51. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345(17):1243–9

    PubMed  CAS  Google Scholar 

  52. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288(3):321–33

    CAS  Google Scholar 

  53. Hormone therapy for the prevention of chronic conditions in postmenopausal women: Recommendations from the U.S. Preventive Services Task Force. Ann Intern Med 2005;142(10):855–60

    Google Scholar 

  54. Executive summary. Hormone therapy. Obstet Gynecol 2004;104(4 Suppl):1S–4S

    Google Scholar 

  55. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 2004;291(5):565–75

    CAS  Google Scholar 

  56. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007;369(9576):1876–82

    PubMed  CAS  Google Scholar 

  57. Spence JD. Homocysteine-lowering therapy: A role in stroke prevention? Lancet Neurol 2007;6(9):830–8

    PubMed  CAS  Google Scholar 

  58. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–52

    PubMed  CAS  Google Scholar 

  59. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review. Stroke 2003;34(11): 2741–8

    PubMed  Google Scholar 

  60. Arboix A, Besses C. Cerebrovascular disease as the initial clinical presentation of haematological disorders. Eur Neurol 1997;37(4):207–11

    PubMed  CAS  Google Scholar 

  61. Liu M, Counsell C, Zhao XL, Wardlaw J. Fibrinogen depleting agents for acute ischaemic stroke. Cochrane Database Syst Rev 2003(3):CD000091

    Google Scholar 

  62. Elkind MS, Cole JW. Do common infections cause stroke? Semin Neurol 2006;26(1):88–99

    PubMed  Google Scholar 

  63. Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: An open-label, evaluator-blinded study. Neurology 2007;69(14):1404–10

    PubMed  CAS  Google Scholar 

  64. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the Third and Fourth Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007;23(1):75–80

    PubMed  Google Scholar 

  65. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: A controlled randomized study. Neurology 2007;69(9):904–10

    PubMed  CAS  Google Scholar 

  66. Amarenco P, Bogousslavsky J, Callahan A, 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355(6):549–59

    PubMed  CAS  Google Scholar 

  67. Goldstein LB. Low LDL cholesterol, statins, and brain hemorrhage: Should we worry? Neurology 2007;68(10):719–20

    PubMed  Google Scholar 

  68. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: Multiple mechanisms of action in the ischemic brain. Neuroscientist 2007;13(3):208–13

    PubMed  CAS  Google Scholar 

  69. Ovbiagele B, Saver JL, Starkman S, et al. Statin enhancement of collateralization in acute stroke. Neurology 2007;68(24):2129–31

    PubMed  CAS  Google Scholar 

  70. Bang O Y. Intracranial atherosclerotic stroke: Specific focus on the metabolic syndrome and inflammation. Curr Atheroscler Rep 2006;8(4):330–6

    PubMed  CAS  Google Scholar 

  71. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: Incidence and etiology. Neurology 2004;62(11):2025–30

    PubMed  CAS  Google Scholar 

  72. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005;4(9):533–42

    PubMed  Google Scholar 

  73. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988;8(Suppl 7):1–96

    Google Scholar 

  74. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. Br Med J 2005;330(7482):63

    Google Scholar 

  75. Arpa J, Cruz-Martinez A, Campos Y, et al. Prevalence and progression of mitochondrial diseases: A study of 50 patients. Muscle Nerve 2003;28(6):690–5

    PubMed  Google Scholar 

  76. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 2006;114(4):217–38

    PubMed  CAS  Google Scholar 

  77. Collop N. The effect of obstructive sleep apnea on chronic medical disorders. Cleve Clin J Med 2007;74(1):72–8

    PubMed  Google Scholar 

  78. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004;3(6):333–42

    PubMed  Google Scholar 

  79. Helms A, Ajayi O, Kittner S. Investigating the link between oral contraceptives and stroke. Pract Neurol 2007;6(4):34–40

    Google Scholar 

  80. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006;107(6):1453–72

    Google Scholar 

  81. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357(22):2262–8

    PubMed  CAS  Google Scholar 

  82. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345(24):1740–6

    PubMed  CAS  Google Scholar 

  83. Redding-Lallinger R, Knoll C. Sickle cell disease — patho-physiology and treatment. Curr Prob Pediatr Adolesc Health Care 2002;36:346–76

    Google Scholar 

  84. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14(3):191–7

    PubMed  Google Scholar 

  85. Adams RJ. Big strokes in small persons. Arch Neurol 2007;64(11):1567–74

    PubMed  Google Scholar 

  86. Adams RJ, Brambilla DJ, Granger S, et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood 2004;103(10):3689–94

    PubMed  CAS  Google Scholar 

  87. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145(3):346–52

    PubMed  CAS  Google Scholar 

  88. Krishnamurti L. Hematopoietic cell transplantation for sickle cell disease: State of the art. Expert Opin Biol Ther 2007;7(2):161–72

    PubMed  CAS  Google Scholar 

  89. Holmes S, Zwar N, Jimenez-Ruiz CA, et al. Bupropion as an aid to smoking cessation: A review of real-life effectiveness. Int J Clin Pract 2004;58(3):285–91

    PubMed  CAS  Google Scholar 

  90. Haggstram FM, Chatkin JM, Sussenbach-Vaz E, Cesari DH, Fam CF, Fritscher CC. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: Preliminary results. Pulm Pharmacol Ther 2006

    Google Scholar 

  91. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007(1):CD006103

    Google Scholar 

  92. Williams KE, Reeves KR, Billing CB, Jr., Pennington AM, Gong J. A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin 2007;23(4):793–801

    PubMed  CAS  Google Scholar 

  93. Administration USFaD. FDA Approves Novel Medication for Smoking Cessation; 2006 May 11, 2006. Report No. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01370.html

  94. Mercadante N. Management of patients with prosthetic heart valves: Potential impact of valve site, clinical characteristics, and comorbidity. J Thromb Thrombolys 2000;10(1):29–34

    CAS  Google Scholar 

  95. Hardman SM, Cowie MR. Fortnightly review: Anticoagulation in heart disease. Br Med J 1999;318(7178):238–44

    CAS  Google Scholar 

  96. Kelley RE. CNS vasculitis. Front Biosci 2004;9:946–55

    PubMed  CAS  Google Scholar 

  97. Younger DS. Vasculitis of the nervous system. Curr Opin Neurol 2004;17(3):317–36

    PubMed  Google Scholar 

  98. Jennette JC, Falk RJ. Nosology of primary vasculitis. Curr Opin Rheumatol 2007;19(1):10–6

    PubMed  Google Scholar 

  99. Kuker W. Cerebral vasculitis: Imaging signs revisited. Neuroradiology 2007;49(6):471–9

    PubMed  Google Scholar 

  100. Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006;54(10):3306–9

    PubMed  Google Scholar 

  101. Melson MR, Weyand CM, Newman NJ, Biousse V. The diagnosis of giant cell arteritis. Rev Neurol Dis 2007;4(3):128–42

    PubMed  Google Scholar 

  102. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population-based study. Arthritis Rheum 2001;45(2):140–5

    PubMed  CAS  Google Scholar 

  103. Ringleb PA, Strittmatter EI, Loewer M, et al. Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) 2005;44(8):1012–5

    CAS  Google Scholar 

  104. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33(8): 1129–34

    PubMed  CAS  Google Scholar 

  105. Reichart MD, Bogousslavsky J, Janzer RC. Early lacunar strokes complicating polyarteritis nodosa: Thrombotic microangiopathy. Neurology 2000;54(4):883–9

    PubMed  CAS  Google Scholar 

  106. Lightfoot RW, Jr., Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33(8):1088–93

    PubMed  Google Scholar 

  107. Lamprecht P, Gross WL. Wegener's granulomatosis. Herz 2004;29(1):47–56

    PubMed  Google Scholar 

  108. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33(8):1101–7

    PubMed  CAS  Google Scholar 

  109. Kang DW, Kim DE, Yoon BW, Seo JW, Roh JK. Delayed diagnosis: Recurrent cerebral infarction associated with Churg-Strauss syndrome. Cerebrovasc Dis 2001;12(3):280–1

    PubMed  CAS  Google Scholar 

  110. Keogh KA, Specks U. Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003;115(4):284–90

    PubMed  CAS  Google Scholar 

  111. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33(8):1094–100

    PubMed  CAS  Google Scholar 

  112. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988;67(1):20–39

    CAS  Google Scholar 

  113. Moore PM. Vasculitis of the central nervous system. Semin Neurol 1994;14(4):307–12

    PubMed  CAS  Google Scholar 

  114. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342(9):635–45

    PubMed  CAS  Google Scholar 

  115. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347(20):1549–56

    PubMed  Google Scholar 

  116. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47(4):337–69

    CAS  Google Scholar 

  117. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23(4):380–4

    PubMed  CAS  Google Scholar 

  118. Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in systemic lupus erythematosus. Stroke 1990;21(11):1533–9

    PubMed  CAS  Google Scholar 

  119. Brust JC. Vasculitis owing to substance abuse. Neurol Clin 1997;15(4):945–57

    PubMed  CAS  Google Scholar 

  120. Niehaus L, Meyer BU. Bilateral borderzone brain infarctions in association with heroin abuse. J Neurol Sci 1998;160(2):180–2

    PubMed  CAS  Google Scholar 

  121. Serdaroglu P. Behcet's disease and the nervous system. J Neurol 1998;245(4):197–205

    PubMed  CAS  Google Scholar 

  122. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke 1988;19(9):1159–70

    PubMed  CAS  Google Scholar 

  123. Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: Cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum 2002;47(6):662–9

    PubMed  Google Scholar 

  124. Calabrese LH. Clinical management issues in vasculitis. Angiographically defined angiitis of the central nervous system: Diagnostic and therapeutic dilemmas. Clin Exp Rheumatol 2003;21(6 Suppl 32):S127–30

    PubMed  CAS  Google Scholar 

  125. Ng YS, Stein J, Ning M, Black-Schaffer RM. Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke 2007;38(8):2309–14

    PubMed  Google Scholar 

  126. Caplan LR. Transient ischemic attack with abnormal diffusion-weighted imaging results: What's in a name? Arch Neurol 2007;64(8):1080–2

    PubMed  Google Scholar 

  127. Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: Diagnostic criteria. Stroke 2003;34(12):2995–8

    PubMed  Google Scholar 

  128. A classification and outline of cerebrovascular diseases. Neurology 1958;8(5):395–434

    Google Scholar 

  129. Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 2006;129(Pt 7):1640–58

    PubMed  Google Scholar 

  130. Bettermann K. Transient global amnesia: The continuing quest for a source. Arch Neurol 2006;63(9):1336–8

    PubMed  Google Scholar 

  131. Roach ES. Transient global amnesia: Look at mechanisms not causes. Arch Neurol 2006;63(9):1338–9

    PubMed  CAS  Google Scholar 

  132. Menendez Gonzalez M, Rivera MM. Transient global amnesia: Increasing evidence of a venous etiology. Arch Neurol 2006;63(9):1334–6

    Google Scholar 

  133. Ali LK, Saver JL. The ischemic stroke patient who worsens: New assessment and management approaches. Rev Neurol Dis 2007;4(2):85–91

    PubMed  Google Scholar 

  134. Brazis PW, Masdeau JC, Biller J. Localization in clinical neurology. Philadelphia, PA: Lippincott; 2007

    Google Scholar 

  135. Ali S, Khan MA, Khealani B. Limb-shaking Transient Ischemic Attacks: Case report and review of literature. BMC Neurol 2006;6:5

    Google Scholar 

  136. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004;35(7):1769–75

    PubMed  Google Scholar 

  137. Murie JA, Sheldon CD, Quin RO. Carotid artery bruit: Association with internal carotid stenosis and intraluminal turbulence. Br J Surg 1984;71(1):50–2

    PubMed  CAS  Google Scholar 

  138. Shorr RI, Johnson KC, Wan J Y, et al. The prognostic significance of asymptomatic carotid bruits in the elderly. J Gen Intern Med 1998;13(2):86–90

    PubMed  CAS  Google Scholar 

  139. Hillis AE. Aphasia: Progress in the last quarter of a century. Neurology 2007;69(2):200–13

    PubMed  Google Scholar 

  140. Chambers BR, Brooder RJ, Donnan GA. Proximal posterior cerebral artery occlusion simulating middle cerebral artery occlusion. Neurology 1991;41(3):385–90

    PubMed  CAS  Google Scholar 

  141. Maulaz AB, Bezerra DC, Bogousslavsky J. Posterior cerebral artery infarction from middle cerebral artery infarction. Arch Neurol 2005;62(6):938–41

    PubMed  Google Scholar 

  142. Hommel M, Besson G, Pollak P, Kahane P, Le Bas JF, Perret J. Hemiplegia in posterior cerebral artery occlusion. Neurology 1990;40(10):1496–9

    PubMed  CAS  Google Scholar 

  143. Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24(1):35–41

    PubMed  Google Scholar 

  144. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337(8756):1521–6

    PubMed  CAS  Google Scholar 

  145. Adams HP, Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38(5):1655–711

    PubMed  Google Scholar 

  146. Johnston SC, Gress DR, Browner WS, Sidney S. Shortterm prognosis after emergency department diagnosis of TIA. J Am Med Assoc 2000;284(22):2901–6

    CAS  Google Scholar 

  147. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283–92

    PubMed  Google Scholar 

  148. Feldmann E, Wilterdink JL, Kosinski A, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007;68(24):2099–106

    PubMed  CAS  Google Scholar 

  149. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17(1):66–72

    PubMed  CAS  Google Scholar 

  150. Rauh R, Fischereder M, Spengel FA. Transesophageal echocardiography in patients with focal cerebral ischemia of unknown cause. Stroke 1996;27(4):691–4

    PubMed  CAS  Google Scholar 

  151. McNamara RL, Lima JA, Whelton PK, Powe NR. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: A cost-effectiveness analysis. Ann Intern Med 1997;127(9):775–87

    PubMed  CAS  Google Scholar 

  152. Angeli S, Del Sette M, Beelke M, Anzola G P, Zanette E. Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol Sci 2001;22(5):353–6

    PubMed  CAS  Google Scholar 

  153. Del Sette M, Dinia L, Rizzi D, Sugo A, Albano B, Gandolfo C. Diagnosis of right-to-left shunt with transcranial Doppler and vertebrobasilar recording. Stroke 2007;38(8):2254–6

    PubMed  Google Scholar 

  154. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasoundenhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351(21):2170–8

    PubMed  CAS  Google Scholar 

  155. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 2002;33(2):497–501

    PubMed  Google Scholar 

  156. Caplan LR. Resolved: Heparin may be useful in selected patients with brain ischemia. Stroke 2003;34(1):230–1

    PubMed  Google Scholar 

  157. Faden AI, Stoica B. Neuroprotection: Challenges and opportunities. Arch Neurol 2007;64(6):794–800

    PubMed  Google Scholar 

  158. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006;37(1):267–73

    PubMed  CAS  Google Scholar 

  159. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345(19):1359–67

    PubMed  Google Scholar 

  160. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354(5):449–61

    PubMed  Google Scholar 

  161. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose— potassium—insulin infusions in the management of poststroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6(5):397–406

    PubMed  CAS  Google Scholar 

  162. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355(18):1903–11

    CAS  Google Scholar 

  163. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: Myth or insanity? Am J Med 2007;120(7):563–7

    PubMed  Google Scholar 

  164. Zaremba J. Hyperthermia in ischemic stroke. Med Sci Monit 2004;10(6):RA148–53

    PubMed  Google Scholar 

  165. Fernandez A, Schmidt JM, Claassen J, et al. Fever after subarachnoid hemorrhage: Risk factors and impact on outcome. Neurology 2007;68(13):1013–9

    PubMed  CAS  Google Scholar 

  166. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346(8):549–56

    Google Scholar 

  167. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346(8):557–63

    PubMed  Google Scholar 

  168. Bhardwaj A, Mirski M, Ulatowski J. Handbook of Neurocritical Care. Totowa, NJ: Humana Press; 2004

    Google Scholar 

  169. Nguyen T, Koroshetz WJ. Intensive care management of ischemic stroke. Curr Neurol Neurosci Rep 2003;3(1):32–9

    PubMed  Google Scholar 

  170. Karepov VG, Gur AY, Bova I, Aronovich BD, Bornstein NM. Stroke-in-evolution: Infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis 2006;21(1–2):42–6

    PubMed  Google Scholar 

  171. Davenport A. The management of renal failure in patients at risk of cerebral edema/hypoxia. New Horiz 1995;3(4):717–24

    PubMed  CAS  Google Scholar 

  172. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6(3):215–22

    PubMed  Google Scholar 

  173. Berges S, Moulin T, Berger E, et al. Seizures and epilepsy following strokes: Recurrence factors. Eur Neurol 2000;43(1):3–8

    PubMed  CAS  Google Scholar 

  174. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986;15(2):84–8

    PubMed  CAS  Google Scholar 

  175. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomised comparison. Lancet 2007;369(9570):1347–55

    PubMed  CAS  Google Scholar 

  176. Epstein NE. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 2005;64(4):295–301; discussion 2

    PubMed  Google Scholar 

  177. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology 1998;50(6):1683–8

    PubMed  CAS  Google Scholar 

  178. Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers: A systematic review. J Am Med Assoc 2006;296(8):974–84

    CAS  Google Scholar 

  179. Martin B. Prevention of gastrointestinal complications in the critically ill patient. AACN Adv Crit Care 2007;18(2):158–66

    PubMed  Google Scholar 

  180. Chemerinski E, Levine SR. Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med 2006;73(7):1006–14

    PubMed  Google Scholar 

  181. Ferro JM, Caeiro L, Verdelho A. Delirium in acute stroke. Curr Opin Neurol 2002;15(1):51–5

    PubMed  Google Scholar 

  182. Caplan LR, Fisher M. The endothelium, platelets, and brain ischemia. Rev Neurol Dis 2007;4(3):113–21

    PubMed  Google Scholar 

  183. Chen WH, Cheng X, Lee P Y, et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med 2007;120(7):631–5

    PubMed  CAS  Google Scholar 

  184. Kreisel SH, Hennerici MG, Bazner H. Pathophysiology of stroke rehabilitation: The natural course of clinical recovery, use-dependent plasticity and rehabilitative outcome. Cerebrovasc Dis 2007;23(4):243–55

    PubMed  Google Scholar 

  185. Mark VW, Taub E, Morris DM. Neuroplasticity and constraint-induced movement therapy. Eura Medicophys 2006;42(3):269–84

    PubMed  CAS  Google Scholar 

  186. O'Malley MK, Ro T, Levin HS. Assessing and inducing neuroplasticity with transcranial magnetic stimulation and robotics for motor function. Arch Phys Med Rehabil 2006;87(12 Suppl 2):S59–66

    PubMed  Google Scholar 

  187. Hogan N, Krebs HI, Rohrer B, et al. Motions or muscles? Some behavioral factors underlying robotic assistance of motor recovery. J Rehabil Res Dev 2006;43(5):605–18

    PubMed  Google Scholar 

  188. Sheffler LR, Chae J. Neuromuscular electrical stimulation in neurorehabilitation. Muscle Nerve 2007;35(5): 562–90

    PubMed  Google Scholar 

  189. Phillips JP, Devier DJ, Feeney DM. Rehabilitation pharmacology: Bridging laboratory work to clinical application. J Head Trauma Rehabil 2003;18(4):342–56

    PubMed  Google Scholar 

  190. Dobkin BH. Behavioral, temporal, and spatial targets for cellular transplants as adjuncts to rehabilitation for stroke. Stroke 2007;38(2 Suppl):832–9

    PubMed  Google Scholar 

  191. Chen J, Chopp M. Neurorestorative treatment of stroke: Cell and pharmacological approaches. NeuroRx 2006;3(4):466–73

    PubMed  CAS  Google Scholar 

  192. Wozniak MA, Kittner SJ. Return to work after ischemic stroke: A methodological review. Neuroepidemiology 2002;21(4):159–66

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Alabama, Birmingham, USA

    Agnieszka Anna Ardelt

Authors
  1. Agnieszka Anna Ardelt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ardelt, A.A. (2009). Acute Ischemic Stroke. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-125-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-125-7_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-755-6

  • Online ISBN: 978-1-60327-125-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation